Eli Lilly

UnitedHealth Group

Johnson & Johnson

AbbVie

Merck

Abbott Labs

Thermo Fisher Scientific

Intuitive Surgical

Amgen

Danaher

iShares U.S. Healthcare ETF

IYH tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US.

Fidelity MSCI Health Care ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

Big stocks are likely to dominate the returns of the healthcare ETF going into Q3 earnings announcements.

What Lies in Store for Healthcare ETFs in Q3 Earnings?

This monthly report analyzes key industry metrics in the healthcare sector. This sector is overvalued by about 20% relative to 11-year averages. Healthcare providers are the least overvalued subsector.

IYH: Healthcare Dashboard For October

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund launched on 06/12/2000.

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

Fidelity MSCI Utilities Index ETF

iShares U.S. Utilities ETF

iShares U.S. Consumer Goods ETF

iShares MSCI USA Quality Factor ETF

Invesco S&P 500 Quality ETF

Vanguard Consumer Staples ETF

Vanguard Utilities ETF

Consumer Staples Select Sector SPDR Fund

Utilities Select Sector SPDR Fund

The "September Effect" adds to the volatility already present in the market, increasing the need for investors to adopt a cautious approach when maintaining their portfolios.

ETFs in Focus Amid September's Market Storm Possibilities

Vanguard Real Estate ETF

Defensive sector ETFs achieve new highs amid a dull start to September.

Defensive ETFs Shine Amid a Rough Start to September

Fidelity MSCI Consumer Staples ETF

Tema Obesity & Cardiometabolic ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Aerospace & Defense ETF

Roundhill GLP-1 & Weight Loss ETF

Invesco Dynamic Pharmaceuticals ETF

Invesco Aerospace & Defense ETF

VanEck Vectors Pharmaceutical ETF

Global X Defense Tech ETF

Amplify Weight Loss Drug & Treatment ETF

SPDR S&P Aerospace & Defense ETF

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

Disruptive Theme of the Week: Playing Defense

With the markets recently experiencing a sharp sell-off which may have dampened investor confidence, increasing bets that the U.S. economy may slip into a recession increases the need to safeguard investor portfolios with defensive bets.

ETFs to Secure Your Portfolio Amid Uncertain Market Conditions

The healthcare sector has gained momentum lately on market rotation, with investors rushing to buy beaten-down stocks while shunning the hot technology sector.

What Lies in Store for Healthcare ETFs in Q2 Earnings?

IYH invests in large-cap U.S. healthcare stocks with strong earnings growth potential. Despite trailing the S&P 500 index in the past year, healthcare stocks are expected to rebound strongly in 2024 and 2025 with better growth rates. Healthcare sector's valuation may be high compared to historical levels, but still lower than the dot-com bubble.

IYH: Strong Performance Expected In The Next Few Years

iShares U.S. Healthcare ETF is a hold due to high valuations, increased competition, and macroeconomic factors.

IYH: How Another Smaller, Equally-Weighted Competitor May Outperform

Horizon Kinetics Medical ETF

Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.

ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook

Bristol-Myers

Pfizer

While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

iShares U.S. Healthcare Providers ETF

UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate on both earnings and revenues.

UnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain

First Trust Nasdaq Pharmaceuticals ETF 

Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.

JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus

ARK Genomic Revolution Multi-Sector ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares U.S. Medical Devices ETF

At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.

Time to Tap Healthcare ETFs on Nvidia's AI Ambition?

Global X Robotics & Artificial Intelligence ETF

First Trust Nasdaq Oil & Gas ETF

VanEck Morningstar Wide Moat ETF

Texas Capital Texas Oil Index ETF

SPDR Portfolio Total Stock Market ETF

Follow Warren Buffett's latest tips and bet on these ETFs.

Buffett's Wisdom: 6 ETF Strategies for Investors

Harbor Health Care ETF

Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat

The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks cheaper than their peers in January 2024.

IYH: Healthcare Dashboard For January

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to adjust drug prices in line with inflation, providing advantage in inflationary environment.

Healthcare In 2024: Navigating The Biopharma Bull Run

The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.

UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus

SPDR S&P 500 ETF Trust

After underperforming in 2023, the healthcare sector seems to be back on track at the start of the New Year. Healthcare generally outperforms during periods of low growth and high uncertainty.

Healthcare ETFs Start 2024 on a Positive Note

iShares U.S. Healthcare ETF provides exposure to the healthcare sector, holding 120 healthcare-related stocks. Healthcare stocks have had varying performances in recent years, with winners and losers in the sector. The increasing prevalence of chronic diseases and longer lifespans present opportunities for drug companies but also risks such as increased scrutiny and regulation.

IYH: Good Way To Gain Exposure To The Healthcare Sector

The possibility of a mild recession, rising fears of an economic slowdown and significant debt levels are some possible headwinds that could dampen the prospects of the economy in 2024. Look into funds to benefit from such a situation.

ETFs to Secure Your Portfolio Amid Potential Economic Fluctuations

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.

Eli Lilly Beats on Q3 Earnings: ETFs to Buy

Kenvue

The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.

News for iShares U.S. Healthcare ETF ETF (IYH)